Standard
Evaluating short-term estrogen as prevention of postpartum depression in women at high risk : the MAMA trial protocol. / Høgh, S.; Hegaard, H. K.; Renault, K. M.; Cvetanovska, E.; Kjærbye-Thygesen, A.; Juul, A.; Borgsted, C.; Bjertrup, A. J.; Miskowiak, K. W.; Væver, M. S.; Stenbaek, D. S.; Dam, V. H.; Ozenne, B.; Frokjaer, V. G.
I:
European Neuropsychopharmacology, Bind 53, 2021, s. S296-S297.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Høgh, S
, Hegaard, HK, Renault, KM, Cvetanovska, E, Kjærbye-Thygesen, A
, Juul, A, Borgsted, C, Bjertrup, AJ
, Miskowiak, KW, Væver, MS, Stenbaek, DS, Dam, VH
, Ozenne, B & Frokjaer, VG 2021, '
Evaluating short-term estrogen as prevention of postpartum depression in women at high risk: the MAMA trial protocol',
European Neuropsychopharmacology, bind 53, s. S296-S297.
https://doi.org/10.1016/j.euroneuro.2021.10.382APA
Høgh, S.
, Hegaard, H. K., Renault, K. M., Cvetanovska, E., Kjærbye-Thygesen, A.
, Juul, A., Borgsted, C., Bjertrup, A. J.
, Miskowiak, K. W., Væver, M. S., Stenbaek, D. S., Dam, V. H.
, Ozenne, B., & Frokjaer, V. G. (2021).
Evaluating short-term estrogen as prevention of postpartum depression in women at high risk: the MAMA trial protocol.
European Neuropsychopharmacology,
53, S296-S297.
https://doi.org/10.1016/j.euroneuro.2021.10.382Vancouver
Høgh S
, Hegaard HK, Renault KM, Cvetanovska E, Kjærbye-Thygesen A
, Juul A o.a.
Evaluating short-term estrogen as prevention of postpartum depression in women at high risk: the MAMA trial protocol.
European Neuropsychopharmacology. 2021;53:S296-S297.
https://doi.org/10.1016/j.euroneuro.2021.10.382Author
Høgh, S. ; Hegaard, H. K. ; Renault, K. M. ; Cvetanovska, E. ; Kjærbye-Thygesen, A. ; Juul, A. ; Borgsted, C. ; Bjertrup, A. J. ; Miskowiak, K. W. ; Væver, M. S. ; Stenbaek, D. S. ; Dam, V. H. ; Ozenne, B. ; Frokjaer, V. G. / Evaluating short-term estrogen as prevention of postpartum depression in women at high risk : the MAMA trial protocol. I: European Neuropsychopharmacology. 2021 ; Bind 53. s. S296-S297.
Bibtex
@article{f1fbb79f145b4c7cbff135919531b5f2,
title = "Evaluating short-term estrogen as prevention of postpartum depression in women at high risk: the MAMA trial protocol",
author = "S. H{\o}gh and Hegaard, {H. K.} and Renault, {K. M.} and E. Cvetanovska and A. Kj{\ae}rbye-Thygesen and A. Juul and C. Borgsted and Bjertrup, {A. J.} and Miskowiak, {K. W.} and V{\ae}ver, {M. S.} and Stenbaek, {D. S.} and Dam, {V. H.} and B. Ozenne and Frokjaer, {V. G.}",
year = "2021",
doi = "10.1016/j.euroneuro.2021.10.382",
language = "English",
volume = "53",
pages = "S296--S297",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
}
RIS
TY - ABST
T1 - Evaluating short-term estrogen as prevention of postpartum depression in women at high risk
T2 - the MAMA trial protocol
AU - Høgh, S.
AU - Hegaard, H. K.
AU - Renault, K. M.
AU - Cvetanovska, E.
AU - Kjærbye-Thygesen, A.
AU - Juul, A.
AU - Borgsted, C.
AU - Bjertrup, A. J.
AU - Miskowiak, K. W.
AU - Væver, M. S.
AU - Stenbaek, D. S.
AU - Dam, V. H.
AU - Ozenne, B.
AU - Frokjaer, V. G.
PY - 2021
Y1 - 2021
U2 - 10.1016/j.euroneuro.2021.10.382
DO - 10.1016/j.euroneuro.2021.10.382
M3 - Conference abstract in journal
VL - 53
SP - S296-S297
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
SN - 0924-977X
ER -
